Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 42519 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before October 22, 2018. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202) 795–7714. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0990–0313 and 

project title for reference, to 

Sherrette.funn@hhs.gov, or call the 

Reports Clearance Officer. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: National Blood 

Collection & Utilization Survey 

(NBCUS). 

Type of Collection: Reinstatement 

without change. OMB No. 0990–0313 

[OS/OASH/OHAIDP]. 

Abstract: Length of request: 3 years. 

Respondents include hospitals that 

perform blood transfusions 

(approximately 2,900); hospitals that 

additionally perform blood donor 

collections (approximately 100), and 

large scale community-based blood 

collection centers (approximately 150). 

The NBCUS is performed once every 

two years. The NBCUS is a biennial 

survey of the blood collection and 

utilization community to produce 

reliable and accurate estimates of 

national and regional collections, 

utilization and safety of all blood 

products. The 2019 NBCUS is funded by 

Department of Health and Human 

Services (DHHS/OASH) and performed 

by the Centers for Disease Control and 

Prevention (CDC). The survey includes 

a core of standard questions on blood 

collection, processing, and utilization 

practices to allow for comparison with 

data from previous surveys. 

Additionally, questions to specifically 

address emerging and developing issues 

and technologies in blood collection 

and utilization are included. Questions 

on transfusion transmitted infections, 

transfusion associated circulatory 

overload, acute hemolysis, delayed 

hemolysis, and severe allergic reactions 

are included in the survey. 

ANNUALIZED BURDEN HOUR TABLE

Forms 

(if necessary) 

Respondents 

(if necessary) 

Number of 

respondents 

Number of 

responses 

per 

respondents 

Average 

burden per 

response 

Total burden 

hours 

(every other 

year) 

NBCUS .............................................. Hospitals ........................................... 3,000 1 1 3,000 

NBCUS .............................................. Blood collection centers ................... 150 1 1 150 

Total ........................................... ........................................................... ........................ 1 ........................ 3,150 

Date: August 17, 2018. 

Terry Clark, 

Office of the Secretary, Asst Paperwork 

Reduction Act Reports Clearance Officer. 

[FR Doc. 2018–18130 Filed 8–21–18; 8:45 am] 

BILLING CODE 4150–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Tobacco Regulatory Science—Behavioral. 

Date: September 24, 2018. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW, 

Washington, DC 20015. 

Contact Person: Wenchi Liang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, 301–435– 

0681, liangw3@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Lung Cellular, Molecular, and 

Immunobiology Study Section. 

Date: September 25–26, 2018. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 West 

Mission Bay Drive, San Diego, CA 92109. 

Contact Person: George M. Barnas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, 301–435– 

0696, barnasg@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 16, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18049 Filed 8–21–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 


amozie on DSK3GDR082PROD with NOTICES1
42520 Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Tinnitus 

Clinical Trial Review. 

Date: September 27, 2018. 

Time: 12:00 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Shiguang Yang, DVM, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, NIDCD, NIH, 6001 

Executive Blvd., Room 8349, Bethesda, MD 

20892, 301–496–8683, yangshi@

nidcd.nih.gov. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel; Clinical 

Trial (U01) Review Meeting. 

Date: October 10, 2018. 

Time: 1:00 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: Kausik Ray, Ph.D., 

Scientific Review Officer, National Institute 

on Deafness and Other Communication 

Disorders, National Institutes of Health, 

Rockville, MD 20850, 301–402–3587, rayk@

nidcd.nih.gov. 

Name of Committee: Communication 

Disorders Review Committee. 

Date: October 18–19, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Eliane Lazar-Wesley, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute on 

Deafness and other Communication 

Disorders/NIH, 6001 Executive Blvd., MSC 

9670, Bethesda, MD 20892–8401, 301–496– 

8683, el6r@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: August 16, 2018 . 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18048 Filed 8–21–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; ESTEEMED (R25) 

Review Meeting (2019/01). 

Date: October 10, 2018. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute of Biomedical Imaging and 

Bioengineering, Two Democracy Plaza, Suite 

920, 6707 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Dennis Hlasta, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

National Institutes of Health, 6707 

Democracy Blvd., Bethesda, MD 20892, 301– 

451–4794, dennis.hlasta@nih.gov. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; Training T32 

Review Meeting (2019/01). 

Date: October 30–31, 2018. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute of Biomedical Imaging and 

Bioengineering, Two Democracy Plaza, Suite 

920, 6707 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: John K. Hayes, Ph.D., 

Scientific Review Officer, National Institute 

of Biomedical Imaging and Bioengineering, 

6707 Democracy Blvd., Suite 959, Bethesda, 

MD 20892, (301) 451–3398, hayesj@nih.gov. 

Dated: August 15, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–18047 Filed 8–21–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Environmental Health Sciences Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Environmental Health Sciences Council. 

Date: September 11–12, 2018. 

Closed: September 11, 2018, 8:30 a.m. to 

10:15 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T.W. Alexander Drive, Research Triangle 

Park, NC 27709. 

Open: September 11, 2018, 10:30 a.m. to 

4:45 p.m. 

Agenda: Discussion of Program and Issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T.W. Alexander Drive, Research Triangle 

Park, NC 27709. 

Open: September 12, 2018, 8:30 a.m. to 

10:30 a.m. 

Agenda: Discussion of Program and Issues. 

Place: Nat. Inst. of Environmental Health 

Sciences, Building 101, Rodbell Auditorium, 

111 T.W. Alexander Drive, Research Triangle 

Park, NC 27709. 

Contact Person: Gwen W. Collman, Ph.D., 

Interim Director, Division of Extramural 

Research & Training, National Institutes of 

Health, Nat. Inst. of Environmental Health 

Sciences, 615 Davis Dr., KEY615/3112, 

Research Triangle Park, NC 27709, (919) 541– 

4980, collman@niehs.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 


amozie on DSK3GDR082PROD with NOTICES1